OKYO Pharma Stock Forecast for 2023 - 2025 - 2030
Updated on 05/05/2024
OKYO Pharma Stock Forecast and Price Target
The average price target for OKYO Pharma's stock set by recognized analysts recently is $7.00, which would result in a potential upside of approximately 360.53% if it reached this mark. The estimation is based on a high estimate of $7.00 and a low estimate of $7.00. Even if you're not interested in OKYO stock, you may be interested in its competitors.
360.53% Upside
OKYO Pharma Fair Value Forecast for 2023 - 2025 - 2030
In the last zero years, Price for OKYO Pharma has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $1.65 – an increase of 100.00%. Over the next six years, experts anticipate that Fair Value growth for OKYO Pharma will be 100.00%.
.jpg)
OKYO Pharma EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, OKYO Pharma's EBITDA has grown, increasing from $-1.21M to $-13.18M – an increase of 989.26%. For the following year, the 0 analysts predict that OKYO Pharma's EBITDA will drop by 53.04%, reaching $-6.19M. In 2030, the professionals' prediction is that OKYO's EBITDA will decrease by 40.68%, reaching $-7.82M.
OKYO Pharma EBIT Forecast for 2023 - 2025 - 2030
OKYO Pharma's EBIT has increased by 990.08% In the last three years, going from $-1.21M to $-13.19M. In the next year, analysts expect EBIT to reach $-15.05M – an increase of 14.10%. According to professionals, by 2030, OKYO Pharma's EBIT will have decreased by 14.53%, falling down to $-11.27M.
OKYO Pharma EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last zero years, EPS for OKYO Pharma has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $-0.40 – an increase of 100.00%. Over the next six years, experts anticipate that EPS growth for OKYO Pharma will be 100.00%.
.jpg)